Home

JOHN K BAKEWELL

CIK 1183553 · SVP, Research & Development · last filed 2026-08-18

JOHN K BAKEWELL is a SVP, Research & Development who has filed 47 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for XTNT, was dated Aug 18, 2026. Across all open-market trades the lifetime net is +$555.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions. 4 SEC filings were submitted jointly with Lantheus Holdings, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.78M

Companies

8

Total Filings

47

Lifetime Open-Market Net

$555.7K

Filer Profile

Reported Address
C/O XTANT MEDICAL HOLDINGS, INC.
664 CRUISER LANE
BELGRADE, MT 59714
Related Filers
Lantheus Holdings, Inc. — 4 joint filings, latest 2016-01-04
EXACT SCIENCES CORP — 2 joint filings, latest 2016-01-05
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XTNT Director 1,129,633 $0.35 $390.6K $0 10 2026-08-18
TMCI Director 454,056 $4.51 $2.05M $594.6K 8 2026-05-19
STIM Director 114,352 $3.03 $346.5K -$38.9K 5 2023-05-26
Corindus Vascular Robotics, Inc. (CVRS) Delisted Director 32,072 — — $0 2 2018-03-06
ENTL Director 0 $7.15 $0 $0 4 2018-03-01
EXACT SCIENCES CORP (EXAS) Delisted Chief Financial Officer — $104.91 — $0 1 2016-01-05
LNTH CFO and Treasurer 0 $100.25 $0 $0 3 2016-01-04
ev3 Inc. (EVVV) Delisted Director 4,148 — — $0 5 2010-07-13

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-18 XTNT Grant (A) +215,517 $0 EDGAR
2026-05-19 TMCI Grant (A) +30,000 $0 EDGAR
2025-11-18 XTNT Grant (A) +158,228 $0 EDGAR
2025-11-18 XTNT Grant (A) +158,228 $0 EDGAR
2025-05-21 TMCI Grant (A) +23,917 $0 EDGAR
2024-08-19 XTNT Grant (A) +162,162 $0 EDGAR
2024-05-22 TMCI Grant (A) +15,091 $0 EDGAR
2024-05-13 TMCI Buy (P) +130,000 $594.6K EDGAR
2023-08-17 XTNT Grant (A) +145,180 $0 EDGAR
2023-05-26 STIM Mixed +21,964 -$38.9K EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.